Saip P - Search Results

1

Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer.

Sen F, Saglam EK, Toker A, Dilege S, Kizir A, Oral EN, Saip P, Sakallioglu B, Topuz E, Aydiner A. Sen F, et al. Among authors: saip p. Cancer Chemother Pharmacol. 2011 Dec;68(6):1497-505. doi: 10.1007/s00280-011-1642-8. Epub 2011 Apr 17. Cancer Chemother Pharmacol. 2011. PMID: 21499895

2

Intraperitoneal cisplatin--mitoxantrone in ovarian cancer patients with minimal residual disease.

Topuz E, Aydiner A, Saip P, Bengisu E, Berkman S, Disci R. Topuz E, et al. Among authors: saip p. Eur J Gynaecol Oncol. 1997;18(1):71-5. Eur J Gynaecol Oncol. 1997. PMID: 9061330 Clinical Trial.

3

Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer.

Topuz E, Saip P, Aydmer A, Salihoğlu Y, Berkman S, Bengisu E. Topuz E, et al. Among authors: saip p. Eur J Gynaecol Oncol. 1998;19(3):265-70. Eur J Gynaecol Oncol. 1998. PMID: 9641228 Clinical Trial.

4

Catheter complications associated with intraperitoneal chemotherapy.

Topuz E, Saip P, Aydiner A, Salihoglu Y, Aydin Y, Topuzlu C. Topuz E, et al. Among authors: saip p. Eur J Gynaecol Oncol. 1998;19(3):275-9. Eur J Gynaecol Oncol. 1998. PMID: 9641230

5

Response evaluation of bone metastases in breast cancer: value of magnetic resonance imaging.

Saip P, Tenekeci N, Aydiner A, Dinçer M, Inanç S, Demir C, Oral EN, Topuz E. Saip P, et al. Cancer Invest. 1999;17(8):575-80. doi: 10.3109/07357909909032842. Cancer Invest. 1999. PMID: 10592764 Clinical Trial.

6

Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer.

Tas F, Aydiner A, Topuz E, Camlica H, Saip P, Eralp Y. Tas F, et al. Among authors: saip p. Acta Oncol. 1999;38(8):1011-5. doi: 10.1080/028418699432275. Acta Oncol. 1999. PMID: 10665754

7

Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.

Topuz E, Salihoglu Y, Aydiner A, Saip P, Tas F, Sozen T, Berkman S, Bengisu E. Topuz E, et al. Among authors: saip p. J Surg Oncol. 2000 Jul;74(3):223-6. doi: 10.1002/1096-9098(200007)74:3<223::aid-jso14>3.0.co;2-q. J Surg Oncol. 2000. PMID: 10951423 Clinical Trial.

8

Angiogenesis and p53 protein expression in breast cancer: prognostic roles and interrelationships.

Tas F, Yavuz E, Aydiner A, Saip P, Disci R, Iplikci A, Topuz E. Tas F, et al. Among authors: saip p. Am J Clin Oncol. 2000 Dec;23(6):546-53. doi: 10.1097/00000421-200012000-00002. Am J Clin Oncol. 2000. PMID: 11202793

9

Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer.

Topuz E, Aydiner A, Saip P, Eralp Y, Taş F, Salihoğlu Y, Tenekeci N. Topuz E, et al. Among authors: saip p. Eur J Gynaecol Oncol. 2000;21(6):599-602. Eur J Gynaecol Oncol. 2000. PMID: 11214619

10

Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.

Tas F, Aydiner A, Topuz E, Yasasever V, Karadeniz A, Saip P. Tas F, et al. Among authors: saip p. J Exp Clin Cancer Res. 2000 Dec;19(4):477-81. J Exp Clin Cancer Res. 2000. PMID: 11277326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters